Apyx Medical (APYX) Net Income towards Common Stockholders (2016 - 2025)
Historic Net Income towards Common Stockholders for Apyx Medical (APYX) over the last 15 years, with Q3 2025 value amounting to -$2.0 million.
- Apyx Medical's Net Income towards Common Stockholders rose 5781.42% to -$2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$14.5 million, marking a year-over-year increase of 4887.84%. This contributed to the annual value of -$23.5 million for FY2024, which is 2538.34% down from last year.
- Latest data reveals that Apyx Medical reported Net Income towards Common Stockholders of -$2.0 million as of Q3 2025, which was up 5781.42% from -$3.8 million recorded in Q2 2025.
- Apyx Medical's Net Income towards Common Stockholders' 5-year high stood at -$1.0 million during Q2 2023, with a 5-year trough of -$9.6 million in Q4 2023.
- Its 5-year average for Net Income towards Common Stockholders is -$4.8 million, with a median of -$4.6 million in 2023.
- Per our database at Business Quant, Apyx Medical's Net Income towards Common Stockholders skyrocketed by 8130.28% in 2023 and then crashed by 54337.59% in 2024.
- Quarter analysis of 5 years shows Apyx Medical's Net Income towards Common Stockholders stood at -$2.0 million in 2021, then tumbled by 201.74% to -$6.1 million in 2022, then crashed by 58.4% to -$9.6 million in 2023, then surged by 51.83% to -$4.6 million in 2024, then soared by 57.13% to -$2.0 million in 2025.
- Its Net Income towards Common Stockholders was -$2.0 million in Q3 2025, compared to -$3.8 million in Q2 2025 and -$4.1 million in Q1 2025.